Identification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk
TENVOL
2 other identifiers
interventional
60
1 country
1
Brief Summary
This research aims to identify and monitor specific kinematic markers associated with patellar tendinopathy in athletes at risk. Using a markerless motion capture system, vertical jump tests will be analyzed to detect early biomechanical changes in the knees, hips, trunk, and ankles. By comparing injured participants, the study seeks to improve early diagnosis and personalized prevention strategies for patellar tendinopathy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 5, 2026
CompletedFirst Posted
Study publicly available on registry
February 12, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2029
February 12, 2026
February 1, 2026
3 years
February 5, 2026
February 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (20)
Variations of knee flexion angle at initial contact at 3 months (only for patients in the patellar tendinopathy group)
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.
Between the initial visit and the 3-month visit
Variations of knee flexion angle at initial contact at 6 months
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.
Between the 3-month visit and the 6-month visit
Variations of knee flexion angle at initial contact at 9 months (only for patients in the patellar tendinopathy group)
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.
Between the 6-month visit and the 9-month visit
Variations of knee flexion angle at initial contact at 12 months
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.
Between the 9-month visit and the 12-month visit
Variations of the maximum knee flexion angle at 3 months (only for patients in the patellar tendinopathy group)
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.
Between the initial visit and the 3-month visit
Variations of the maximum knee flexion angle at 6 months
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.
Between the 3-month visit and the 6-month visit
Variations of the maximum knee flexion angle at 9 months (only for patients in the patellar tendinopathy group)
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.
Between the 6-month visit and the 9-month visit
Variations of the maximum knee flexion angle at 12 months
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.
Between the 9-month visit and the 12-month visit
Variations of the range of motion (ROM) of the knee between initial contact and maximum flexion angle at 3 months (only for patients in the patellar tendinopathy group)
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.
Between the initial visit and the 3-month visit
Variations of the range of motion (ROM) of the knee between initial contact and maximum flexion angle at 6 months
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.
Between the 3-month visit and the 6-month visit
Variations of the range of motion (ROM) of the knee between initial contact and maximum flexion angle at 9 months (only for patients in the patellar tendinopathy group)
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.
Between the 6-month visit and the 9-month visit
Variations of the range of motion (ROM) of the knee between initial contact and maximum flexion angle at 12 months
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.
Between the 9-month visit and the 12-month visit
Variations of the angle at the peak of the vertical ground reaction force (VGRF) at 3 months (only for patients in the patellar tendinopathy group)
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.
Between the initial visit and the 3-month visit
Variations of the angle at the peak of the vertical ground reaction force (VGRF)at 6 months
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.
Between the 3-month visit and the 6-month visit
Variations of the angle at the peak of the vertical ground reaction force (VGRF) at 9 months (only for patients in the patellar tendinopathy group)
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.
Between the 6-month visit and the 9-month visit
Variations of the angle at the peak of the vertical ground reaction force (VGRF) at 12 months
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.
Between the 9-month visit and the 12-month visit
Comparison of variation between healthy group and patellar tendinopathy group of knee flexion angle at initial contact at 6 months
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.
Between the two 6-month visits of the two groups
Comparison between the healthy group and the patellar tendinopathy group of variation of the maximum knee flexion angle at 6 months
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.
Between the two 6-month visits of the two groups
Comparison between the healthy group and the patellar tendinopathy group of variations of the range of motion (ROM) of the knee between initial contact and maximum flexion angle at 6 months
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.
Between the two 6-month visits of the two groups
Comparison between the healthy group and the patellar tendinopathy group of variations of the angle at the peak of the vertical ground reaction force (VGRF)at 6 months
The participant will perform the required vertical jump tests. The kinematic data will be captured by the investigating physical therapist specializing in motion analysis using a camera and markerless technology.
Between the two 6-month visits of the two groups
Secondary Outcomes (16)
Variations of the angle of flexion of the trunk, hips, knees, and ankles at initial contact at 3 months (only for patients in the patellar tendinopathy group)
Between the initial visit and the 3-month visit
Variations of the angle of flexion of the trunk, hips, knees, and ankles at initial contact at 6 months
Between the 3-month visit and the 6-month visit
Variations of the angle of flexion of the trunk, hips, knees, and ankles at initial contact at 9 months (only for patients in the patellar tendinopathy group)
Between the 6-month visit and the 9-month visit
Variations of the angle of flexion of the trunk, hips, knees, and ankles at initial contact at 12 months
Between the 9-month visit and the 12-month visit
Variations of the maximum flexion angle of the trunk, hips, knees, and ankles upon landing at 3 months (only for patients in the patellar tendinopathy group)
Between the initial visit and the 3-month visit
- +11 more secondary outcomes
Study Arms (2)
patellar tendinopathy group
EXPERIMENTALDiagnostic Test: The intervention consists of a series of vertical jump tests captured using high-resolution cameras with markerless motion capture technology.
healthy group
OTHERDiagnostic Test: The intervention consists of a series of vertical jump tests captured using high-resolution cameras with markerless motion capture technology.
Interventions
Participants will undergo clinical evaluations including the Single Leg Decline Squat (SLDS) test, VISA-PF, OSTRC-P questionnaires, and Doppler ultrasound of the patellar tendon. These assessments will take place at baseline (T0) and follow-up periods (M3, M6, M9, M12) to track the evolution of kinematic markers and clinical symptoms related to patellar tendinopathy.
Participants will undergo clinical evaluations including the Single Leg Decline Squat (SLDS) test, VISA-PF, OSTRC-P questionnaires, and Doppler ultrasound of the patellar tendon. These assessments will take place at baseline (T0) and follow-up periods ( M6 et M12) to track the evolution of kinematic markers and clinical symptoms related to patellar tendinopathy.
Eligibility Criteria
You may qualify if:
- Patients with at least 2 of the following 3 criteria:
- Modified Öhberg score ≥2 according to L Öhberg, H Alfredson (2002)
- VISA-PF \< 80/100 according to Kaux et al. (2016) and/or OSTRC P ≥ 6/100 according to Owoeye et al. (2018)
- Single Leg Decline Squat (SLDS): VAS ≥ 1/10 with pain mapping at the patellar tendon; according to Coombes et al. (2020)
- Patients with 0 or 1 of the following 3 criteria:
- Modified Öhberg score ≥2 according to L Öhberg, H Alfredson (2002)
- VISA-PF \< 80/100 according to Kaux et al. (2016) and/or OSTRC P ≥ 6/100 according to Owoeye et al. (2018)
- Single Leg Decline Squat (SLDS): VAS ≥ 1/10 with pain mapping at the patellar tendon; according to Coombes et al. (2020)
- Significant medical and surgical history involving the lower limbs (e.g., ACL ligament reconstruction, meniscectomy, etc.)
- Contraindications to participating in sports activities
- Other pathologies involving the lower limbs (\< 6 months), e.g., torn knee ligaments, ankle sprain, knee sprain, etc.
- Participants who have not given their informed consent
- Participants subject to legal protection measures (legal guardianship, conservatorship, curatorship)
- Participants deprived of their liberty by judicial or administrative decision
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sports Medicine and Traumatology LAPEYRONIE Hospital - Montpellier University Hospital
Montpellier, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 5, 2026
First Posted
February 12, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
May 1, 2029
Study Completion (Estimated)
May 1, 2029
Last Updated
February 12, 2026
Record last verified: 2026-02